secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biohaven Ltd. (BHVN)
CIK:        0001935979
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0001628280-26-030579
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biohaven establishes $350M at-the-market equity offering via amended agreement with J.P. Morgan
--------------------------------------------------------------------------------

- Amendment No. 2 to Equity Distribution Agreement allows up to $350M in common share sales.
- J.P. Morgan Securities acts as manager for ATM program on NYSE at prevailing market prices.
- New shelf registration (File No. 333-295531) and prospectus supplement filed May 4, 2026.
- Proceeds for general corporate purposes; timing and amount depend on market conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1935979/000162828026030579/0001628280-26-030579-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1935979/000162828026030579/bhvn-20260504.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-030579

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer